Oculus Innovative Sciences

Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Type
Public
HQ
Petaluma, US
Employees
34 (est)
Oculus Innovative Sciences is headquartered in Petaluma, US

Oculus Innovative Sciences Locations

Petaluma, US
Herten, NL

Oculus Innovative Sciences Metrics

Oculus Innovative Sciences Summary

Market capitalization

$20.9 M

Closing share price

$4.87
Oculus Innovative Sciences's current market capitalization is $20.9 M.

Oculus Innovative Sciences Financials

Oculus Innovative Sciences's revenue is $15.1 M in FY, 2016 which is 8.88% increase from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$13.7 M$13.9 M$15.1 M

Gross profit

$8.4 M$7.29 M$7.21 M

Operating income

$-6.05 M$-6.66 M$-10.2 M

Operating expense total

$14.4 M$13.9 M$17.4 M

Net Income

$3.74 M$-8.2 M$-10.2 M

Operating cash flow

$-2.42 M$656 K$1.33 M

    Oculus Innovative Sciences Market Value History

    We estimate that Oculus Innovative Sciences's current employees are approximately 6% female and 94% male.

    Oculus Innovative Sciences Online Presence

    Oculus Innovative Sciences News

    Oculus Innovative Sciences Company Life

    You may also be interested in